IDEXX Laboratories Market Sentiment

SPY765.54+0.38%QQQ742.80+0.41%BTC/USD84,175.59+0.74%DIA510.23+0.33%GLD381.00+0.04%TLT77.77−0.01%

IDEXX Laboratories Inc

IDXXNASDAQ

Trade with Public

$522.19

-11.25-2.11%

Last update: Sep 30, 6:18 PM

$522.11

-11.33-2.12%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

IDEXX Laboratories Market Sentiment - Benzinga

IDEXX Laboratories Market Sentiment

Market sentiment signals for IDEXX Laboratories (IDXX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▲ 2.8% short float

Options Flow▼ 1.58 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Neutral

12 analysts

Options Flow (P/C)

1.58

More puts — Bearish

19 calls · 30 puts

Avg Consensus PT

$675

+29.3%

Highest Price Target

$805

+54.2%

Morgan Stanley

Lowest Price Target

$475

-9.0%

B of A Securities

Short Interest

2.8%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 11, 2026	Barclays	Glen Santangelo—	+36.0%	$800 → $710	Maintained	Overweight
Aug 5, 2026	UBS	Andrea Alfonso—	+28.3%	$620 → $670	Maintained	Neutral
Aug 5, 2026	Citigroup	Daniel Grosslight—	+28.3%	$650 → $670	Maintained	Neutral
Jul 27, 2026	UBS	Andrea Alfonso—	+18.7%	$640 → $620	Maintained	Neutral
Apr 28, 2026	UBS	Andrea Alfonso—	+22.6%	$730 → $640	Maintained	Neutral
Apr 15, 2026	Citigroup	Daniel Grosslight—	+24.5%	$650	Initiate	Neutral
Mar 31, 2026	Stifel	Jonathan Block—	+29.3%	$775 → $675	Maintained	Buy
Feb 9, 2026	Piper Sandler	David Westenberg—	+43.6%	$775 → $750	Maintained	Neutral
Feb 5, 2026	Barclays	Glen Santangelo—	+53.2%	$850 → $800	Maintained	Overweight
Feb 3, 2026	UBS	Andrea Alfonso—	+39.8%	$750 → $730	Maintained	Neutral
Feb 3, 2026	BTIG	Mark Massaro—	+53.2%	$830 → $800	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	+62.8%	$850	Initiate	Overweight
Nov 4, 2025	Morgan Stanley	Erin Wright—	+54.2%	$765 → $805	Maintained	Overweight
Nov 4, 2025	UBS	Andrea Alfonso—	+43.6%	$710 → $750	Maintained	Neutral
Nov 4, 2025	JP Morgan	Chris Schott—	+48.4%	$675 → $775	Maintained	Overweight
Nov 4, 2025	BTIG	Mark Massaro—	+59.0%	$785 → $830	Maintained	Buy
Oct 31, 2025	Stifel	Jonathan Block—	+34.1%	$640 → $700	Upgrade	Hold→Buy
Oct 1, 2025	UBS	Andrea Alfonso—	+37.9%	$720	Initiate	Neutral
Aug 15, 2025	Morgan Stanley	Erin Wright—	+46.5%	$722 → $765	Maintained	Overweight
Aug 11, 2025	Piper Sandler	David Westenberg—	+34.1%	$510 → $700	Maintained	Neutral
Aug 4, 2025	Morgan Stanley	Erin Wright—	+38.3%	$626 → $722	Maintained	Overweight
Aug 4, 2025	JP Morgan	Chris Schott—	+29.3%	$550 → $675	Maintained	Overweight
Jul 29, 2025	Morgan Stanley	Erin Wright—	+20.3%	$548 → $628	Maintained	Overweight
Jul 17, 2025	Leerink Partners	Daniel Clark—	+14.9%	$580 → $600	Maintained	Outperform
Jul 2, 2025	Stifel	Jonathan Block—	+3.4%	$510 → $540	Maintained	Hold

More with Benzinga EdgeGet Access

Insider & Market Activity News

Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories

In a new SEC filing on September 9, it was revealed that Kingsley, Board Member at IDEXX Laboratories (NASDAQ:IDXX), executed a significant exercise of company stock options. What Happened: Disclosed in a Form 4 filing

Benzinga Insights

Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K

In a new SEC filing on August 24, it was revealed that Emerson, EVP at IDEXX Laboratories (NASDAQ:IDXX), executed a significant exercise of company stock options. What Happened: A Form 4 filing with the U.S. Securities

Benzinga Insights

Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771

Benzinga Insights

Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $771

Benzinga Insights

In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Value

Benzinga Insights

Karen Peacock At IDEXX Laboratories Exercises Options Worth $0

Benzinga Insights

IDEXX Laboratories Inc

IDEXX Laboratories Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

Insider & Market Activity News

Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories

Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K

Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771

Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $771

In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Value

Karen Peacock At IDEXX Laboratories Exercises Options Worth $0

People Also Watch

Bulls vs Bears

People Also Watch